BeStock  
Markets › Compare › ANRO vs JBIO

ANRO vs JBIO

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ANRO · Alto Neuroscience$25.37 ▼ 4.30%
JBIO · Jade Biosciences$15.31 ▲ 1.66%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

85135186236286Nov 24, '25May 26, '26Nov 20, '26
  • ANRO +90.8%
  • JBIO +26.0%

Head to head

MetricANROJBIO
Price$25.37$15.31
Change today▼ 4.30%▲ 1.66%
Market cap$1.02B$1.06B
Return, 3 months-30.0%-28.2%
Return, year to date+42.5%-0.8%
Return, 1 year+91.5%+27.6%
P/E (TTM)––
P/B3.42.3
P/E percentile vs own 5y5th11th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)-77.2%-39.2%
Gross margin––
Operating margin––
Net margin––
Return on equity-46.6%-51.4%
Analyst target vs. price+85.3%+244.0%
Analyst buy share100%100%
RSI (14)4951
30-day volatility87.8%53.3%
Max drawdown, 1 year-40.7%-50.1%
Trend readLeaning bearishLeaning bullish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • JBIO is the largest of the group by market value.
  • ANRO has returned the most over the past year.
  • JBIO has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top